A detailed history of D. E. Shaw & Co., Inc. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 37,471 shares of TERN stock, worth $219,580. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,471
Holding current value
$219,580
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $68,183 - $113,464
10,506 Added 38.96%
37,471 $312,000
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $41,654 - $75,235
9,175 Added 51.57%
26,965 $183,000
Q1 2024

May 15, 2024

BUY
$4.86 - $8.19 $86,459 - $145,700
17,790 New
17,790 $116,000
Q1 2023

May 15, 2023

BUY
$7.91 - $12.0 $369,887 - $561,144
46,762 New
46,762 $553,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.